Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Liposomal Bupivacaine (Exparel) in Soft Tissue Sarcoma Resection

NCT03867188 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03867188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03867188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Liposomal Bupivacaine (Exparel) in Soft Tissue Sarcoma Resection
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Terminated
Start date
January 14, 2019
Completion date
June 11, 2019
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma, soft tissue tumor, soft tissue tumor and/or sarcoma